| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on July 14, 2004
Accepted on January 18, 2005
-Hydroxysteroid Dehydrogenase Deficiency
RN MÜLLER, University Department of Growth and Reproduction, GR-5064, Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen, Denmark (T.H.J.; J.M.; K.M.M.); Laboratoire de Biologie Endocrinienne et Moléculaire, INSERM-EA3539, Hôpital Debrousse, 29 rue Soeur Bouvier, 69322 Lyon Cedex 05, France (D.M.; Y.M.; M.G.F.); and University Department of Clinical Physiological and Nuclear Medicine, Glostrup University Hospital, Nordre Ringvej, DK-2600 Glostrup, Denmark (H.D.-P)
* To whom correspondence should be addressed. E-mail: trinejohannsen{at}rh.dk.
Classical 3
-hydroxysteroid dehydrogenase (3
-HSD) deficiency is a rare cause of congenital adrenal hyperplasia (CAH). We report two sisters presenting with delayed diagnoses of classical 3
-HSD, despite salt wasting (SW) episodes in infancy. Sibling 1 was referred for premature pubarche, slight growth acceleration and advanced bone age, while sibling 2 had no signs of virilization.
At referral, increased 17
-hydroxyprogesterone (17-OHP) associated with premature pubarche at first suggested a non-classical 21-hydroxylase deficiency. Sequencing of the CYP21 gene showed both girls only heterozygotes (V281L mutation). This result, combined with SW in infancy, suggested a 3
-HSD deficiency because of increased DHAS levels. Further hormonal studies showed markedly elevated
(5)-steroids, in particular 17
-hydroxypregnenolone > 100 nmol/liter (the clue to the diagnosis) and elevated
(5)-/
(4)-steroid ratios. Sequencing of the type II 3
-HSD gene documented that both girls were compound heterozygotes for T181I and 1105delA mutations. Retrospectively, elevated levels of 17-OHP were found on blood spots from Guthrie's test.
There is no previous report of the combination of SW and premature pubarche due to mutations in the type II 3
-HSD gene. As neonatal diagnosis could have prevented life threatening crises in these girls, this report further supports the benefits for neonatal screening for CAH whatever the etiology.
-hydroxysteroid dehydrogenase deficiency
congenital adrenal hyperplasia
premature pubarche
salt loss
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |